ArticleTranslational lung cancer research2025
Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC).
Omali Pitiyarachchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it